Project Grant R01AI195754
- Federal Grant Award Summary The University of California, San Diego received a $438,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 21, 2025, with a completion date of June 30, 2027. This award supports the development of new tools to facilitate drug discovery targeting pathogen proteasomes, which represent an emerging therapeutic target for treating parasitic...
- Federal Project Grant Award Summary The University of California, San Diego received a $438,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 8, 2025, through June 30, 2027. The award supports basic immunological research focused on understanding the mechanisms that regulate immunoglobulin gene rearrangement, specifically investigating how enhancers and epigenetic...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of California, San Diego a $3.19 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 16, 2025, with a completion date of June 30, 2029. This grant funds investigator-initiated biomedical research examining the roles and regulation of tissue-resident CD8 T cells during persistent viral infection, utilizing the lymphocytic...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $438,500 Project Grant to the University of California, San Diego under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 8, 2025, with a completion date of June 30, 2027. This award funds investigator-initiated biomedical research examining the sequence-specific determinants and impacts of NS2 (nonstructural protein 2) interactions with the Influenza A Virus...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded UC San Diego a Project Grant totaling $720,035 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and advance a novel therapeutic platform for treating severe multidrug-resistant pulmonary infections. The award, obligated on February 2, 2026, with a completion date of January 31, 2031, funds the research and development of "Living Microrobot...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $720,021 Project Grant to the University of California, San Diego under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 6, 2026, with a completion date of January 31, 2031. This research initiative focuses on developing broadly protective immunization strategies against Group A Streptococcus (Strep A) by designing M protein-based immunogens that elicit...
- Federal Project Grant Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $160,040 to The Regents of the University of California, San Francisco under the Allergy and Infectious Diseases Research program (CFDA 93.855) on December 26, 2025, with completion anticipated by June 30, 2028. This grant supports fundamental research investigating how the opportunistic pathogen Pseudomonas aeruginosa senses and responds to mechanical deformation of its...
- Federal Grant Award Summary The University of California, San Diego received a $3.02 million Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) awarded July 8, 2025, with a completion date of June 30, 2029. This grant funds basic immunological research investigating the Treg-IL-27 axis in immune regulation, specifically examining how regulatory T (Treg) cells produce interleukin-27 (IL-27) to...
- Federal Grant Award Summary The University of California, San Diego received a $395,692 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 17, 2025, with a completion date of June 30, 2030. The project, titled "Enhancing Bacteriophage Function with Coevolution and Synthetic Biology," addresses the critical public health threat of antimicrobial resistance (AMR)...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of California, San Diego a Project Grant totaling $804,705 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 20, 2026, with a completion date of January 31, 2031. The research project investigates the mechanisms of vaccine interference induced by pre-existing anti-staphylococcal antibodies and B cells in response to Staphylococcus...
The University of California, San Diego received a $449,578 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 1, 2026 through January 31, 2031. This award supports investigator-initiated biomedical research focused on understanding the molecular mechanisms of lytic polysaccharide monooxygenases (LPMOs) in bacterial pathogenesis and immunity. Specifically, the research program investigates the role of chitin-binding protein D (CBPD), a highly conserved LPMO of Pseudomonas aeruginosa, in bacterial virulence and host-pathogen interactions, with the ultimate objective of developing CBPD as a protective antigen against PA infections. The project addresses critical knowledge gaps regarding the precise molecular actions of LPMOs, identifies host binding partners for CBPD, and assesses the impact of enzymatic activity on host-pathogen interactions. Research activities conducted at the La Jolla, California facility will involve experimental investigations building upon prior published findings demonstrating that CBPD contributes to bacterial resistance against host complement defenses and that immunization with CBPD provides protective immunity in murine infection models. This research directly supports NIAID's mission to advance scientific knowledge of infectious disease mechanisms and develop therapeutic interventions to improve health outcomes.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $449.6k | 2/1/26 |